812c Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor, Induces Clinical Remission in Patients With Moderate-to-Severe Crohn's Disease: Results From the Phase 2 FITZROY Study Interim Analysis
| Autor: | Vermeire, Severine, Schreiber, Stefan, Petryka, Robert, Kuehbacher, Tanja, Hebuterne, Xavier, Roblin, Xavier, Klopocka, Maria, Goldis, Adrian, Wisniewska-Jarosinska, Maria A., Baranovsky, Andrei, Sike, Robert, Tasset, Chantal T., Van der Aa, Annegret, Harrison, Pille |
|---|---|
| Zdroj: | In Gastroenterology April 2016 150(4) Supplement 1:S1267-S1267 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|